Suplatast Tosilate affects the Initial Increase in Specific IgE and Interleukin-4 during Immunotherapy for Perennial Allergic Rhinitis

References

• Robinson D, Hamid Q, Sun Y, et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992; 326: 298–304.
   PubMed Web of Science ®Google Scholar
• Mosmann TR, Coffman RL. Heterogeneity of cytokine secretion patterns and functions of helper T-cells. Adv Immunol 1989; 46: 111–47.
   PubMed Web of Science ®Google Scholar
• Maggi E, Parronchi P, Manetti R, et al. Receiprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Thl and Th2 clones. J Immunol 1992; 148: 2142–7.
   PubMed Web of Science ®Google Scholar
• Abehsira-Amar 0, Gilbert M, Joliy M, Theze J, Jankovic D. IL-4 plays a dominant role in the differen-tial development of THO into TH1 and TH2 cells. J Immunol 1992; 148: 3820–9.
   Google Scholar
• Finkelman FD, Holmes J, Katona HM, et al. Lymphokine control of in vivo immunoglobulin iso-type selection. Annu Rev Immunol 1990; 8: 303–33.
   PubMed Web of Science ®Google Scholar
• Schleimer RP, Sterbinsky SA, Kaiser J, et al. Inter-leukin-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium: associa-tion with expression of VCAM-1. J Immunol 1992; 148: 1086–92.
   PubMed Web of Science ®Google Scholar
• Hanifin JM, Schneider LC, Leung DYM, et al. Recom-binant interferon gamma therapy for atopic dermatitis. J Am Acad Dermatol 1993; 28: 189–97.
   PubMed Web of Science ®Google Scholar
• Pene J, Rousset F, Briere F, et al. IgE production by normal human B cells induced by alloreactive T-cell clones is mediated by IL-4 and suppressed by IFN-y. J Immunol 1988; 141: 1218–24.
   PubMed Web of Science ®Google Scholar
• Kopf M, Le Gros G, Bachman M, Lamers MC, Bleuthmann H, Kohler G. Disruption of the murine IL-4 gene blocks TH2 cytokine responses. Nature 1993; 362: 245–8.
   PubMed Web of Science ®Google Scholar
• Koda A, Yanagihara Y, Matsuura N. IPD-1151T: a prototype drug for IgE antibody synthesis modulation. Agents Action 1991; Suppl 34: 369–78.
   Google Scholar
• Tsubura E, Kobayashi S, Makino S, et al. Clinical evaluation of IPD-1151T on adult bronchial asthma: A multicenter double-blind comparative dose finding study. Jpn Pharmacol Ther 1992; 20: 3197–290.
   Google Scholar
• Baba S, Takasaka T, Baba K, et al. Long term treat-ment of IPD-1151T on allergic rhinitis. Jpn Pharmacol Ther 1992; 20: 3243–59.
   Google Scholar
• Matsuura N, Yanagihara Y, Mori H, Nagai H, Koda A. An immunopharmacological study of ()4244-3- ethoxy-2-hydroxypropoxy)phenylcarbamoyflethyl]dimethylsulfonium p-toluenesulfonate (Suplatast Tosi-late, IPS-1151T). 1. Effect of IPD-1151T on IgE anti-body formation in mice and rats. Jpn Pharmacol Ther 1994; 22: 1369–83.
   Google Scholar
• Yanagihara Y, Kiniwa M, Ikizawa K, et al. Suppres-sion of IgE production by IPD-1151T (suplatast tosi-late). a new dimethylsulfonium agent: 1. Regulation of murine IgE response. Jpn J Pharmacol 1993; 61: 23–30.
   Google Scholar
• Yanagihara Y, Kiniwa M, Ikizawa K, Shida T, Matsu-ura N, Koda A. Suppression of IgE production by IPD-1151T (suplatast tosilate). a new dimethylsulfo-nium agent: 2. regulation of human IgE response. Jpn J Pharmacol 1993; 61: 31–9.
   Google Scholar
• Corrado OJ, Pastorello E, O11ier S, et al. A double-blind study of hyposensitization with an alginate conju-gated extract of D. pteronyssinus (Conjuvac') in patients with perennial rhinitis. 1. Clinical aspects. Allergy 1989; 44: 108–15.
   Google Scholar
• McHugh SM, Lavelle B, Kemeny DM, et al. A placebo-controlled trial of immunotherapy with two extracts of Dermatophagoides pteronyssinus in allergic rhinitis, comparing clinical outcome with changes in antigen-specific IgE, IgG, and IgG subclasses. J Allergy Clin Immunol 1990; 86: 521–32.
   PubMed Web of Science ®Google Scholar
• Ohashi Y, Nakai Y, Okamoto H, et al. Significant correlation between symptom score and IgG4 antibody titer following long-term immunotherapy for perennial allergic rhinitis. Ann Otol Rhinol Laryngol 1997; 106: 483–9.
   PubMed Web of Science ®Google Scholar
• Tsai LC, Hung MW, Tang RB. Changes of serum-spe-cific IgE antibody titer during hyposensitization in mite-sensitive asthmatic children. J Asthma 1990; 27: 95–100.
   Google Scholar
• Kato S, Nakai Y, Ohashi Y, Kato M. RAST in diagnosis and therapy of allergic rhinitis. Acta Otolar-yngol (Stockh) 1991; Suppl 486: 209–16.
   Google Scholar
• Okuda M, Ishikawa T, Saito Y, et al. A clinical evaluation of N'-5 with perennial-type allergic rhinitis: a test by multi-clinic, intergroup, double-blind compar-ative method. Ann Allergy 1984; 53: 178–85.
   PubMedGoogle Scholar
• 41st World Medical Assembly. Declaration of Helsinki: recommendations guiding physicians in biomedical re-search involving human subjects. Bull Pan Am Health Organ 1990; 24: 606–9.
   Google Scholar
• Ohashi Y, Nakai Y, Sakamoto H, et al. Serum levels of soluble interleukin-2 receptor in patients with perennial allergic rhinitis before and after immunotherapy. Ann Allergy Asthma Immunol 1996; 77: 203–8.
   PubMed Web of Science ®Google Scholar
• Ohashi Y, Ohno Y, Okamoto H, et al. Clinical evalua-tion of lumiward immunoassay system for measure-ment of Japanese cedar pollen-specific IgE antibodies. Pract Otol (Kyoto) 1996; 89: 575–81.
   Google Scholar
• Ohashi Y, Nakai Y, Sakamoto H, et al. Serum level of interleukin-4 in patients with perennial allergic rhinitis during allergen-specific immunotherapy. Scand J Im-munol 1996; 43: 680–6.
   PubMed Web of Science ®Google Scholar
• Ohashi Y, Nakai Y, Kakinoki Y, et al. Immunother-apy affects the seasonal increase in specific IgE and interleukin-4 in the serum of patients with seasonal allergic rhinitis. Scand J Immunol 1997; 46: 67–77.
   PubMed Web of Science ®Google Scholar
• Matsumoto T, Miike T, Yamaguchi K, Muranaka M, Kawabe T, Yodoi J. Serum levels of soluble IL-2 receptor, IL-4 and IgE-binding factors in childhood allergic diseases. Clin Exp Immunol 1991; 85: 288–92.
   PubMed Web of Science ®Google Scholar
• Reddy MM, Weissman AM, Mazza DS, et al. Circulat-ing elevated levels of soluble CD23, interleukin-4, and CD20± CD23± lymphocytes in atopic subjects with elevated serum IgE concentrations. Ann Allergy 1992; 69: 131–4.
   PubMedGoogle Scholar
• Ohashi Y, Nakai Y, Ohno Y, et al. Natural course of serum-specific immunoglobulin E and immunoglobulin G4 for a span of eight years in untreated patients with perennial allergic rhinitis. Laryngoscope 1997; 107: 382–5.
   PubMed Web of Science ®Google Scholar
• Ohashi Y, Nakai Y, Tanaka A, et al. Seasonal rise in interleukin-4 during pollen season is related to seasonal rise in specific IgE but not for mites. Acta Otolaryngol (Stockh) 1998; 118: 243–7.
   PubMed Web of Science ®Google Scholar